Martin Volkmann
Zentrallabor
Medizinische Klinik und Poliklinik
Universität Heidelberg
Germany
Name/email consistency: high
- Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression. Volkmann, M., Sinn, H.P., Gaugel, D., Frey, M., Hajjar, Y., Ludwig, J., Hänsel, S., Bastert, G., Wallwiener, D., Fiehn, W., Zentgraf, H., Huober, J. Oncology (2002)
- Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis. Volkmann, M., Martin, L., Bäurle, A., Heid, H., Strassburg, C.P., Trautwein, C., Fiehn, W., Manns, M.P. Hepatology (2001)
- Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma. Volkmann, M., Schiff, J.H., Hajjar, Y., Otto, G., Stilgenbauer, F., Fiehn, W., Galle, P.R., Hofmann, W.J. J. Mol. Med. (2001)
- CDKN2 mutation is infrequent in german hepatocellular carcinoma. Volkmann, M., Stilgenbauer, F., Hofmann, W.J., Otto, G., Schiff, J.H., Fiehn, W. Oncology (1999)